797 related articles for article (PubMed ID: 27152637)
1. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
2. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
4. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
[TBL] [Abstract][Full Text] [Related]
5. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
8. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
Han JJ; Tarney CM; Song J
Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
[TBL] [Abstract][Full Text] [Related]
9. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.
Rambout L; Hopkins L; Hutton B; Fergusson D
CMAJ; 2007 Aug; 177(5):469-79. PubMed ID: 17671238
[TBL] [Abstract][Full Text] [Related]
11. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
Frazer IH
Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
13. [The first vaccine against cancer: the human papillomavirus vaccine].
Bősze P
Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccines and adolescents.
Kahn JA; Bernstein DI
Curr Opin Obstet Gynecol; 2005 Oct; 17(5):476-82. PubMed ID: 16141761
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the impact of human papillomavirus vaccines.
Chang Y; Brewer NT; Rinas AC; Schmitt K; Smith JS
Vaccine; 2009 Jul; 27(32):4355-62. PubMed ID: 19515467
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus disease and vaccines.
Hutchinson DJ; Klein KC
Am J Health Syst Pharm; 2008 Nov; 65(22):2105-12. PubMed ID: 18997137
[TBL] [Abstract][Full Text] [Related]
17. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]